SouthState Bank Corp
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 764038
WINTER HAVEN, FL
Position in VRTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$20,987
-$7,121 QoQ
Shares Held
47
-24.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 91.48936170212765.ToString("F0")%
Shared 0.ToString("F0")%
None 8.51063829787234.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SouthState Bank Corp holds $76,515 across 22 Biotechnology names. VRTX ranks #1 (27.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
47 | $20,987 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23 | $17,770 | |
| 3 | CBUS |
Cibus, Inc.
|
3,511 | $6,951 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13 | $4,301 | |
| 5 | INCY |
Incyte Corp
|
41 | $3,858 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
19 | $3,591 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
50 | $2,378 | |
| 8 | TECH |
BIO-TECHNE Corp
|
45 | $2,351 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,987 | 47 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $28,108 | 62 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $18,407 | 47 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $34,725 | 78 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $62,056 | 128 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $6,845 | 17 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $4,185 | 9 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $4,218 | 9 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $836 | 2 | Shares | Defined | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||